Jimi Biotech
Jimi Biotech develops delicious meat directly from animal cells, without slaughtering.
Jimi Biotech develops delicious meat directly from animal cells, without slaughtering.
Jimi Biotech is a cultivated meat company based in China, aiming to revolutionize the food industry by developing delicious meat directly from animal cells, without slaughtering. Founded in 2021, the company has made significant strides in the field of biotechnology, producing the first cultivated beef in China in the same year. Jimi Biotech is committed to addressing the public health, environmental pollution, and animal welfare problems caused by industrial animal farming. The company secured an Angel Round investment on 08 March 2023, with Shiwei Venture Capital as the lead investor, signaling confidence from notable backers in the industry. With a strong focus on reducing production costs through scientific breakthroughs, Jimi Biotech is poised to make a substantial impact in the global meat industry.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Angel Round | Unknown | 1 | Shiwei Venture Capital | 08 Mar 2023 |
| Angel Round | CNY20.00M | 6 |
|
14 Nov 2022 |
No recent news or press coverage available for Jimi Biotech.
We care about your data, and we'd love to use cookies make your experience better.